论文部分内容阅读
随着全球人口老龄化,生活工作压力大,绝经过渡期异常子宫出血发生呈上升趋势,且治疗后复发率高。该病确诊后,应当以止血、减少月经量,防止子宫内膜癌变为治疗原则。分为药物及非药物治疗,前者主要有性激素和非激素类止血药物;非药物治疗包括诊断性刮宫、左炔诺孕酮宫内释放系统、介入治疗、子宫内膜去除及子宫切除术。近年来,大量研究对绝经过渡期异常子宫出血治疗方面进行了分析,为提高疗效,减少并发症,降低复发率,笔者通过查阅相关文献资料,并结合临床实践,本文就绝经过渡期异常子宫出血治疗进展做一综述,并对其发展趋势进行展望。
With the global population aging, stressful life and work, abnormal uterine bleeding during the menopause transition is on the rise, and the relapse rate is high after treatment. After the diagnosis of the disease, hemostasis should be to reduce the amount of menstruation, prevention of endometrial cancer into treatment principles. Divided into drug and non-drug treatment, the former mainly of sex hormones and non-hormone hemostatic drugs; non-drug treatment, including diagnostic curettage, levonorgestrel intrauterine release system, interventional therapy, endometrial removal and hysterectomy. In recent years, a large number of studies on the treatment of abnormal uterine bleeding during the menopause transition were analyzed, in order to improve the efficacy, reduce complications and reduce the recurrence rate, the author through access to relevant literature, combined with clinical practice, this article menopause transitional abnormal uterine bleeding The progress of treatment is reviewed and its development trend is forecasted.